ACQUISITION AGREEMENT among SAVIENT PHARMACEUTICALS, INC. AND SAVIENT PHARMA HOLDINGS, INC., as Sellers, and US WORLDMEDS, LLC AND SLOAN HOLDINGS C.V. as Purchaser Parties Dated as of October 14, 2013Acquisition Agreement • October 15th, 2013 • Savient Pharmaceuticals Inc • Medicinal chemicals & botanical products • Delaware
THIS ACQUISITION AGREEMENT, dated as of October 14, 2013 (this “Agreement”), is made among Savient Pharmaceuticals, Inc., a Delaware corporation (the “Parent”), its wholly-owned subsidiary, Savient Pharma Holdings, Inc., a Delaware corporation (the “Seller Subsidiary,” and together with the Parent, the “Sellers”), US WorldMeds, LLC, a Delaware limited liability company (the “Purchaser Owner”), and its wholly-owned direct and indirect subsidiary, Sloan Holdings C.V., a Netherlands Commanditaire Vennootschap (the “Purchaser” and together with the Purchaser Owner, the “Purchaser Parties”). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in Article IX.
